PATH has adapted, developed, or co-developed more than 85 technologies designed to improve the health and lives of people in developing countries. Amongst others, these include: vaccine vial monitors that detect when temperature-sensitive vaccines have been exposed to heat; single-use, disposable syringes that prevent needle re-use; ‘ultra-rice’ technology that uses manufactured, rice-like grains fortified with micro-nutrients to alleviate malnutrition; and a pre-filled injection device that ensures the correct amounts of vaccines or drugs are administered. Reflecting the organization’s deep impact, several billion of these products are presently in use worldwide.
Most recently, PATH introduced the ‘MenAfriVac’ vaccine in partnership with the World Health Organization. As a result, more than 20 million people in Burkina Faso, Mali, and Niger were vaccinated against meningitis A, which has ravaged sub-Saharan Africa for more than a century.